Interestingly, an increased fraction of the cell population was found to express CD44 + / CD24 - / ESA
+ cell surface markers.
Not exact matches
In breast cancer, CSCs or tumor - initiating
cells were first identified by using a combination of
cell surface markers, CD24 − / CD44
+ / ESA (EpCAM)
+ (2).
By means of a non-obese diabetic / severe combined immunodeficiency disease (NOD / SCID) xenotransplant assay in combination with specific
cell surface markers (CD44
+ CD24 - / low), CSCs were enriched from metastatic and primary breast tumors and were shown to have the ability to reestablish tumor heterogeneity after transplantation [1].
Positive clones were then differentiated using defined serum - free conditions outlined in Ng, et al [7], which overall gave rise to a CD45
+ CD56
+ CD117 − CD94
+ population of cytotoxic NK
cells [8] expressing the CD4 construct and other
surface markers in a similar manner to peripheral blood NK
cells.
The B
cell depleted fraction was then
surface stained for lineage
markers (CD3, CD19, CD14), CD127 and
cells were sorted (Lin - CD127
+).
g defined serum - free conditions outlined in Ng, et al [7], which overall gave rise to a CD45
+ CD56
+ CD117 − CD94
+ population of cytotoxic NK
cells [8] expressing the CD4 construct and other
surface markers in a similar manner to peripheral blood NK
cells.